FOP Australia are proud to release the Annual Report for financial year 2016/17.
During the 2016/17 year:
- Significant milestones were reached in the global research effort, including planning for the first phase III clinical trial of palovarotene
- Supporters of FOP Australia greatly exceeded our fundraising goal, with over $37,000 donated
- Electronic platforms set up to help with fundraising activities, direct donation and electronic membership renewal
- FOP Australia expanded member communications with commencement of regular newsletters and clinician updates
Read more in the report, which includes our financial statements and independent auditor’s report, and ideas for how you can help.
As part of our ongoing strategic planning and commitment to accountability, the key performance indicators we have set for the 2017/18 year are also available online here.
Thank you again for your support in 2016/17, and for continuing to support us in 2017/18!